| APH |
Report |
Net Sales (Q2 2026) |
BEAT |
pred ~$8.70B vs. cons $8.296B |
HIGH |
| APH |
Report |
Adj. EPS - Operating (Q2 2026) |
BEAT |
pred ~$1.25 vs. cons $1.183 |
HIGH |
| APH |
Report |
IT Datacom Revenue (Q2 2026) |
BEAT |
pred ~$3.70B vs. cons $3.603B |
MEDIUM |
| APH |
Guide |
Net Sales (Q3 2026) |
BETTER |
guide ~$9.6-10.0B vs. cons ~$9.0B (UNVERIFIED) |
MEDIUM |
| APH |
Guide |
Adj. EPS (Q3 2026) |
BETTER |
guide ~$1.30-1.35 vs. cons ~$1.30 (UNVERIFIED) |
MEDIUM |
| APH |
Guide |
Book-to-Bill (Q2 2026) |
UNCHANGED |
pred ~1.10-1.15x vs. cons 1.15x |
MEDIUM |
| APH |
Return |
Day-1 residual (stock − beta × S&P 500) |
+6.0% |
— |
MEDIUM |
| APH |
Return |
5-day cumulative residual |
+8.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — FY estimates revised up after beat + Q3 guide above consensus; stock de-rated pre-earnings removes the fade risk seen in Q4 2025 and Q1 2026 |
MEDIUM |